ANRO
Alto Neuroscience, Inc.
Company overview
- Market capitalization
- $1.05B
- Employees
- 68
- Latest publication
- 2026-09-29
About Alto Neuroscience, Inc.
Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's product pipeline includes ALTO-100, which is in Phase 2b clinical trial for the treatment of patients with bipolar depression (BPD). It also develops ALTO-300, a small molecule melatonergic agonist and serotonergic antagonist with antidepressant properties, which is in Phase 2b clinical trial to treat patients with major depressive disorder (MDD); ALTO-101, a novel small molecule phosphodiesterase 4 inhibitor that is in Phase 2 proof-of-concept (POC) trial for the treatment of cognitive impairment associated with schizophrenia; ALTO-203, a novel small-molecule histamine H3 receptor inverse agonist, which is in Phase 2 POC trial to treat patients with MDD and higher levels of anhedonia; ALTO-202, an investigational orally bioavailable antagonist of the GluN2B subunit of the NMDA receptor that is in Phase 1 clinical trial for the treatment of MDD; and ALTO-208, a fixed-dose combination of pramipexole and aprepitant, an antiemetic, neurokinin-1 (NK-1) receptor antagonist for patients with Parkinson's disease for patients with Parkinson's disease. The company was incorporated in 2019 and is headquartered in Mountain View, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-03-31 · USD | Q1 20262025-12-31 · USD | Q4 20252025-09-30 · USD | Q3 20252025-06-30 · USD | Q2 20252025-03-31 · USD | Q1 20252024-12-31 · USD | Q4 20242024-09-30 · USD | Q3 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 394,000USD | 0USD | 0USD |
| Cost Of Revenue | 184,000USD | 157,000USD | 164,000USD | 100,000USD | 171,000USD | 170,000USD | 200,000USD | 100,000USD |
| Gross Profit | -184,000USD | -157,000USD | -164,000USD | -100,000USD | -171,000USD | -170,000USD | -200,000USD | -100,000USD |
| Research Development | 20,294,000USD | 11,996,000USD | 10,525,000USD | 13,124,000USD | 9,974,000USD | 10,800,000USD | 13,060,000USD | 13,184,000USD |
| Selling General Administrative | 6,844,000USD | 5,059,000USD | 4,426,000USD | 5,558,000USD | 5,702,000USD | 6,197,000USD | 5,826,000USD | 5,157,000USD |
| Total Operating Expenses | 26,954,000USD | -115,673,000USD | 14,951,000USD | 18,582,000USD | 15,676,000USD | 16,827,000USD | 18,886,000USD | 18,341,000USD |
| Operating Income | -27,138,000USD | 115,673,000USD | -14,951,000USD | -18,682,000USD | -15,676,000USD | -16,997,000USD | -18,886,000USD | -18,341,000USD |
| Interest Income | 1,561,000USD | 1,561,000USD | 1,532,000USD | 1,683,000USD | 1,827,000USD | 2,135,000USD | 2,500,000USD | 2,658,000USD |
| Interest Expense | 545,000USD | 575,000USD | 650,000USD | 646,000USD | 598,000USD | 333,000USD | 349,000USD | 347,000USD |
| Net Interest Income | 1,016,000USD | 986,000USD | 882,000USD | 1,037,000USD | 1,229,000USD | 1,802,000USD | 2,151,000USD | 2,311,000USD |
| Income Before Tax | -26,237,000USD | -16,182,000USD | -14,181,000USD | -17,706,000USD | -15,169,000USD | -15,201,000USD | -16,783,000USD | -16,030,000USD |
| Net Income | -26,237,000USD | -16,182,000USD | -14,181,000USD | -17,706,000USD | -15,169,000USD | -15,201,000USD | -16,783,000USD | -16,030,000USD |
| Net Income From Continuing Ops | -26,237,000USD | -16,182,000USD | -14,181,000USD | -17,706,000USD | -15,169,000USD | -15,201,000USD | -16,783,000USD | -16,030,000USD |
| Ebit | -27,138,000USD | -15,607,000USD | -13,531,000USD | -17,060,000USD | -14,571,000USD | -14,868,000USD | -16,434,000USD | -15,683,000USD |
| Ebitda | -26,954,000USD | -15,450,000USD | -13,367,000USD | -16,960,000USD | -14,400,000USD | -14,698,000USD | -16,312,000USD | -15,570,000USD |
| Depreciation And Amortization | 184,000USD | 157,000USD | 164,000USD | 100,000USD | 171,000USD | 170,000USD | 122,000USD | 113,000USD |
| Reconciled Depreciation | 184,000USD | 157,000USD | 164,000USD | 169,000USD | 171,000USD | 170,000USD | 122,000USD | 113,000USD |
| Total Other Income Expense Net | 901,000USD | -131,855,000USD | 770,000USD | 976,000USD | 507,000USD | 1,796,000USD | 2,103,000USD | 2,311,000USD |
| Unclassified Operating Expenses | — | -132,728,000USD | — | — | — | — | — | — |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 100,000USD |
| Income Tax Expense | — | — | — | — | — | — | — | -1USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-09-30 · USD | FY 20242024-09-30 · USD | FY 20232023-09-30 · USD | FY 20222022-09-30 · USD | FY 20212021-09-30 · USD |
|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 210,000USD |
| Cost Of Revenue | 661,000USD | 502,000USD | 373,000USD | 342,000USD | 145,000USD |
| Gross Profit | -661,000USD | -502,000USD | -373,000USD | -342,000USD | 65,000USD |
| Research Development | 45,619,000USD | 46,996,000USD | 30,291,000USD | 23,688,000USD | 8,370,000USD |
| Selling General Administrative | 20,745,000USD | 21,614,000USD | 7,518,000USD | 5,504,000USD | 3,896,000USD |
| Total Operating Expenses | 65,703,000USD | 68,108,000USD | 37,809,000USD | 28,850,000USD | 12,121,000USD |
| Operating Income | -66,364,000USD | -68,610,000USD | -37,809,000USD | -29,192,000USD | -12,056,000USD |
| Interest Income | 6,603,000USD | 8,851,000USD | 2,349,000USD | 114,000USD | 2,000USD |
| Interest Expense | 2,469,000USD | 1,375,000USD | 1,370,000USD | 0USD | — |
| Net Interest Income | 4,134,000USD | 7,476,000USD | 979,000USD | 114,000USD | 2,000USD |
| Income Before Tax | -63,238,000USD | -61,431,000USD | -36,305,000USD | -27,710,000USD | -9,187,000USD |
| Net Income | -63,238,000USD | -61,431,000USD | -36,305,000USD | -27,710,000USD | -9,187,000USD |
| Net Income From Continuing Ops | -63,238,000USD | -61,431,000USD | -36,305,000USD | -27,710,000USD | -9,187,000USD |
| Ebit | -66,364,000USD | -62,806,000USD | -34,935,000USD | -27,710,000USD | -9,187,000USD |
| Ebitda | -65,703,000USD | -68,610,000USD | -34,562,000USD | -27,368,000USD | -9,042,000USD |
| Depreciation And Amortization | 661,000USD | -5,804,000USD | 373,000USD | 342,000USD | 145,000USD |
| Reconciled Depreciation | 661,000USD | 502,000USD | 373,000USD | 342,000USD | 145,000USD |
| Total Other Income Expense Net | 3,126,000USD | 7,179,000USD | 1,504,000USD | 1,482,000USD | 2,869,000USD |
| Income Tax Expense | — | -61,431,000USD | — | — | — |
| Selling And Marketing Expenses | — | — | 373,000USD | 342,000USD | 145,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262025-12-31 · USD | Q4 20252025-09-30 · USD | Q3 20252025-06-30 · USD | Q2 20252025-03-31 · USD | Q1 20252024-12-31 · USD | Q4 20242024-09-30 · USD | Q3 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 254,066,000USD | 184,689,000USD | 147,006,000USD | 157,877,000USD | 171,915,000USD | 177,542,000USD | 191,608,000USD | 197,360,000USD |
| Cash And Equivalents | 243,733,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 247,319,000USD | 177,718,000USD | 139,448,000USD | 149,846,000USD | 163,523,000USD | 169,337,000USD | 183,526,000USD | 195,414,000USD |
| Other Current Assets | 3,586,000USD | 1,234,000USD | 1,632,000USD | 2,261,000USD | 2,769,000USD | 1,108,000USD | 1,825,000USD | 2,292,000USD |
| Total Liabilities | 34,817,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 16,652,000USD | 11,325,000USD | 9,045,000USD | 8,129,000USD | 7,257,000USD | 10,008,000USD | 14,015,000USD | 9,843,000USD |
| Other Current Liabilities | 8,863,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 219,249,000USD | 151,142,000USD | 111,557,000USD | 123,412,000USD | 139,096,000USD | 151,460,000USD | 165,052,000USD | 179,776,000USD |
| Total Equity Including Noncontrolling Interest | 219,249,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 3,768,000USD | 585,000USD | — | — | — | — | 3,529,000USD | 2,317,000USD |
| Long Term Debt | 12,419,000USD | 18,399,000USD | 22,438,000USD | 22,122,000USD | 21,151,000USD | 11,558,000USD | 7,925,000USD | 7,741,000USD |
| Property Plant Equipment Net | 5,909,000USD | 6,133,000USD | 6,488,000USD | 6,961,000USD | 7,323,000USD | 7,701,000USD | 7,578,000USD | 1,442,000USD |
| Accounts Payable | 4,021,000USD | 1,878,000USD | 2,059,000USD | 1,671,000USD | 1,384,000USD | 1,579,000USD | 2,252,000USD | 1,843,000USD |
| Short Term Debt | 1,361,000USD | 1,736,000USD | 1,118,000USD | 973,000USD | 876,000USD | 870,000USD | 4,245,000USD | 2,317,000USD |
| Retained Earnings | -255,509,000USD | -201,634,000USD | -185,452,000USD | -171,271,000USD | -153,565,000USD | -138,396,000USD | -123,195,000USD | -106,412,000USD |
| Accumulated Other Comprehensive Income | 17,000USD | 22,000USD | 14,000USD | 31,000USD | 14,000USD | -101,000USD | -95,000USD | -89,000USD |
| Total Liab | — | 33,546,999USD | 35,449,000USD | 34,465,000USD | 32,819,000USD | 26,082,000USD | 26,556,000USD | 17,584,000USD |
| Other Current Liab | — | 7,711,000USD | 5,868,000USD | 5,485,000USD | 4,997,000USD | 7,559,000USD | 7,518,000USD | 5,683,000USD |
| Common Stock | — | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD |
| Capital Stock | — | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD |
| Cash | — | 176,484,000USD | 137,816,000USD | 147,585,000USD | 160,754,000USD | 168,229,000USD | 181,701,000USD | 193,122,000USD |
| Cash And Short Term Investments | — | 176,484,000USD | 137,816,000USD | 147,585,000USD | 160,754,000USD | 168,229,000USD | 181,701,000USD | 193,122,000USD |
| Net Debt | — | -152,526,000USD | -110,294,000USD | -120,276,000USD | -134,316,000USD | -151,285,000USD | -164,915,000USD | -183,064,000USD |
| Short Long Term Debt Total | — | 23,958,000USD | 27,522,000USD | 27,309,000USD | 26,438,000USD | 16,944,000USD | 16,786,000USD | 10,058,000USD |
| Property Plant Equipment Gross | — | 7,659,000USD | 7,857,000USD | 8,283,000USD | 8,478,000USD | 8,705,000USD | 8,487,000USD | 2,233,000USD |
| Common Stock Shares Outstanding | — | 31,923,521shares | 27,104,000shares | 27,072,000shares | 27,049,000shares | 26,986,560shares | 26,959,000shares | 26,950,590shares |
| Non Current Assets Total | — | 6,971,000USD | 7,558,000USD | 8,031,000USD | 8,392,000USD | 8,205,000USD | 8,082,000USD | 1,946,000USD |
| Non Current Liabilities Total | — | 22,221,999USD | 26,404,000USD | 26,336,000USD | 25,562,000USD | 16,074,000USD | 12,541,000USD | 7,741,000USD |
| Non Currrent Assets Other | — | 338,000USD | 1,070,000USD | 570,000USD | 569,000USD | 4,000USD | 4,000USD | 4,000USD |
| Net Working Capital | — | 166,393,000USD | 130,403,000USD | 141,717,000USD | 156,266,000USD | 159,329,000USD | 169,511,000USD | 185,571,000USD |
| Unclassified Non Current Liabilities | — | 3,822,999USD | 3,966,000USD | 4,214,000USD | 4,411,000USD | 4,516,000USD | 4,616,000USD | — |
| Unclassified Equity | — | 352,748,000USD | 296,989,000USD | 294,646,000USD | 292,641,000USD | 289,951,000USD | 288,336,000USD | 286,271,000USD |
| Unclassified Current Liabilities | — | — | — | — | — | — | -3,529,000USD | -2,317,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-09-30 · USD | FY 20242024-09-30 · USD | FY 20232023-09-30 · USD | FY 20222022-09-30 · USD | FY 20212021-09-30 · USD |
|---|---|---|---|---|---|
| Total Assets | 184,689,000USD | 177,542,000USD | 86,628,000USD | 50,854,000USD | 28,794,000USD |
| Other Current Assets | 1,234,000USD | 1,108,000USD | 2,835,000USD | 330,000USD | 236,000USD |
| Total Liab | 33,547,000USD | 26,082,000USD | 158,300,000USD | 89,260,000USD | 41,272,000USD |
| Total Stockholder Equity | 151,142,000USD | 151,460,000USD | -71,672,000USD | -38,406,000USD | -12,478,000USD |
| Other Current Liab | 8,862,000USD | 7,559,000USD | 4,411,000USD | 3,671,000USD | 1,210,000USD |
| Common Stock | 3,000USD | 3,000USD | — | 1,000USD | 1,000USD |
| Capital Stock | 3,000USD | 3,000USD | 0USD | 1,000USD | 0USD |
| Retained Earnings | -201,634,000USD | -138,396,000USD | -76,965,000USD | -40,660,000USD | -12,950,000USD |
| Cash | 176,484,000USD | 168,229,000USD | 82,548,000USD | 48,344,000USD | 25,705,000USD |
| Cash And Short Term Investments | 176,484,000USD | 168,229,000USD | 82,548,000USD | 48,344,000USD | 25,705,000USD |
| Total Current Assets | 177,718,000USD | 169,337,000USD | 85,391,000USD | 49,220,000USD | 27,684,000USD |
| Total Current Liabilities | 11,325,000USD | 10,008,000USD | 5,610,000USD | 5,560,000USD | 1,810,000USD |
| Net Debt | -172,076,000USD | -151,285,000USD | -72,562,000USD | 33,762,000USD | 12,458,000USD |
| Short Term Debt | 585,000USD | 870,000USD | 125,000USD | 283,000USD | — |
| Short Long Term Debt | 585,000USD | — | — | — | — |
| Short Long Term Debt Total | 4,408,000USD | 16,944,000USD | 9,986,000USD | 82,106,000USD | 38,163,000USD |
| Long Term Debt | 18,399,000USD | 11,558,000USD | 9,861,000USD | 9,465,000USD | — |
| Accounts Payable | 1,878,000USD | 1,579,000USD | 1,074,000USD | 1,606,000USD | 600,000USD |
| Property Plant Equipment Net | 6,133,000USD | 7,701,000USD | 1,106,000USD | 1,579,000USD | 1,060,000USD |
| Property Plant Equipment Gross | 7,659,000USD | 8,705,000USD | 1,790,000USD | 1,752,000USD | 1,304,000USD |
| Accumulated Other Comprehensive Income | 22,000USD | -101,000USD | -79,000USD | -46,000USD | -22,000USD |
| Common Stock Shares Outstanding | 28,852,000shares | 24,602,000shares | 26,883,988shares | 25,574,360shares | 25,574,360shares |
| Non Current Assets Total | 6,971,000USD | 8,205,000USD | 1,237,000USD | 1,634,000USD | 1,110,000USD |
| Non Current Liabilities Total | 22,222,000USD | 16,074,000USD | 152,690,000USD | 83,700,000USD | 39,462,000USD |
| Non Currrent Assets Other | 338,000USD | 4,000USD | 131,000USD | 55,000USD | 50,000USD |
| Net Working Capital | 166,393,000USD | 159,329,000USD | 79,781,000USD | 43,660,000USD | 25,874,000USD |
| Unclassified Non Current Liabilities | 3,823,000USD | 4,516,000USD | 142,829,000USD | 74,112,000USD | 39,462,000USD |
| Unclassified Equity | 352,748,000USD | 289,951,000USD | 5,372,000USD | 2,298,000USD | — |
| Other Assets | — | — | 1USD | — | 1USD |
| Net Receivables | — | — | 8,000USD | 546,000USD | 1,743,000USD |
| Non Current Liabilities Other | — | — | — | 123,000USD | — |
| Inventory | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 368,000USD |
| Stock Based Compensation | 6,378,000USD |
| Other Non Cash Items | 0USD |
| Change To Liabilities | 1,601,000USD |
| Change In Working Capital | -210,000USD |
| Operating Cash Flow | -46,851,000USD |
| Capital Expenditures | -556,000USD |
| Investing Cash Flow | -556,000USD |
| Net Debt Issuance | 0USD |
| Net Common Stock Issuance | -190,000USD |
| Unclassified Financing Cash Flow | 114,858,000USD |
| Financing Cash Flow | 114,668,000USD |
| Effect Of Forex Changes On Cash | -12,000USD |
| Change In Cash | 67,249,000USD |
| End Cash Flow | 244,233,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q2 20262026-03-31 · USD | Q1 20262025-12-31 · USD | Q4 20252025-09-30 · USD | Q3 20252025-06-30 · USD | Q2 20252025-03-31 · USD | Q1 20252024-12-31 · USD | Q4 20242024-09-30 · USD | Q3 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -26,237,000USD | -16,181,999USD | -14,181,000USD | -17,706,000USD | -15,169,000USD | -15,201,000USD | -16,783,000USD | -16,030,000USD |
| Depreciation | 184,000USD | 157,000USD | 164,000USD | 169,000USD | 171,000USD | 170,000USD | 135,000USD | 113,000USD |
| Stock Based Compensation | 2,824,000USD | 1,946,000USD | 2,189,000USD | 2,005,000USD | 1,968,000USD | 1,566,000USD | 1,998,000USD | 1,888,000USD |
| Other Non Cash Items | 3,355,000USD | 2,408,999USD | 613,000USD | 458,000USD | 1,133,000USD | 345,000USD | 138,000USD | 905,000USD |
| Change In Working Capital | -4,393,000USD | 2,100,000USD | 1,297,000USD | 1,295,000USD | -4,659,000USD | 99,000USD | 2,786,000USD | 1,430,000USD |
| Total Cash From Operating Activities | -27,091,000USD | -11,516,000USD | -9,918,000USD | -13,779,000USD | -16,556,000USD | -13,021,000USD | -11,726,000USD | -11,694,000USD |
| Capital Expenditures | -556,000USD | 0USD | 0USD | 0USD | -24,000USD | -506,000USD | -1,005,000USD | -340,000USD |
| Free Cash Flow | -27,647,000USD | -11,516,000USD | -9,918,000USD | -13,779,000USD | -16,580,000USD | -13,527,000USD | -12,731,000USD | -12,034,000USD |
| Total Cashflows From Investing Activities | -556,000USD | — | — | — | -24,000USD | -506,000USD | -1,005,000USD | -340,000USD |
| Net Borrowings | 0USD | 0USD | 0USD | 0USD | 9,475,000USD | — | 0USD | — |
| Total Cash From Financing Activities | 114,941,000USD | 50,185,000USD | 153,000USD | 613,000USD | 9,127,000USD | 49,000USD | 1,317,000USD | -234,000USD |
| Sale Purchase Of Stock | -4,875,000USD | -167,000USD | — | 0USD | 0USD | — | 100,000USD | — |
| Issuance Of Capital Stock | 120,000,000USD | 50,000,000USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Change In Cash | 87,278,000USD | 38,668,000USD | -9,769,000USD | -13,169,000USD | -7,475,000USD | -13,472,000USD | -11,421,000USD | -12,273,000USD |
| Begin Period Cash Flow | 176,484,000USD | 137,816,000USD | 147,585,000USD | 161,254,000USD | 168,729,000USD | 182,201,000USD | 193,622,000USD | 205,895,000USD |
| End Period Cash Flow | 263,762,000USD | 176,484,000USD | 137,816,000USD | 148,085,000USD | 161,254,000USD | 168,729,000USD | 182,201,000USD | 193,622,000USD |
| Other Cashflows From Financing Activities | -190,000USD | — | 153,000USD | 419,000USD | -546,000USD | 49,000USD | 1,317,000USD | -234,000USD |
| Unclassified Operating Cash Flow | -2,824,000USD | -1,946,000USD | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | 120,006,000USD | 50,352,000USD | — | — | — | — | — | — |
| Investments | — | — | 0USD | 0USD | -24,000USD | -506,000USD | -1,005,000USD | -340,000USD |
| Change To Account Receivables | — | — | — | — | — | — | -8,000USD | — |
| Unclassified Investing Cash Flow | — | — | — | — | — | — | 1,005,000USD | — |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | — | -340,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-09-30 · USD | FY 20242024-09-30 · USD | FY 20232023-09-30 · USD | FY 20222022-09-30 · USD | FY 20212021-09-30 · USD |
|---|---|---|---|---|---|
| Net Income | -63,238,000USD | -61,431,000USD | -36,305,000USD | -27,710,000USD | -9,187,000USD |
| Depreciation | 661,000USD | 502,000USD | 373,000USD | 342,000USD | 145,000USD |
| Stock Based Compensation | 8,108,000USD | 7,631,000USD | 2,891,000USD | 1,763,000USD | 227,000USD |
| Other Non Cash Items | 2,667,000USD | 1,814,000USD | 291,000USD | 632,000USD | 125,000USD |
| Change In Working Capital | 33,000USD | 4,060,000USD | -698,000USD | 4,579,000USD | -572,000USD |
| Total Cash From Operating Activities | -51,769,000USD | -47,424,000USD | -33,448,000USD | -20,394,000USD | -9,262,000USD |
| Capital Expenditures | -24,000USD | -2,075,000USD | -470,000USD | -732,000USD | -680,000USD |
| Free Cash Flow | -51,793,000USD | -49,499,000USD | -33,918,000USD | -21,126,000USD | -9,942,000USD |
| Total Cashflows From Investing Activities | -24,000USD | -2,075,000USD | -470,000USD | -732,000USD | -680,000USD |
| Net Borrowings | 9,475,000USD | 0USD | 0USD | 9,825,000USD | 0USD |
| Total Cash From Financing Activities | 60,078,000USD | 135,691,000USD | 68,130,000USD | 43,789,000USD | 31,688,000USD |
| Sale Purchase Of Stock | -167,000USD | 0USD | — | — | — |
| Issuance Of Capital Stock | 50,000,000USD | 137,579,000USD | 70,181,000USD | 34,305,000USD | 31,893,000USD |
| Change In Cash | 8,255,000USD | 86,181,000USD | 34,204,000USD | 22,639,000USD | 21,696,000USD |
| Begin Period Cash Flow | 168,729,000USD | 82,548,000USD | 48,344,000USD | 25,705,000USD | 4,009,000USD |
| End Period Cash Flow | 176,984,000USD | 168,729,000USD | 82,548,000USD | 48,344,000USD | 25,705,000USD |
| Other Cashflows From Financing Activities | 60,078,000USD | -3,138,000USD | 68,130,000USD | 33,921,000USD | 31,681,000USD |
| Unclassified Financing Cash Flow | -9,308,000USD | 138,829,000USD | -70,181,000USD | -34,262,000USD | -31,886,000USD |
| Investments | — | -2,075,000USD | -470,000USD | -732,000USD | -680,000USD |
| Unclassified Investing Cash Flow | — | 2,075,000USD | — | — | — |
| Change To Account Receivables | — | — | 325,000USD | 1,158,000USD | -1,285,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.